Xenos Mason is a Neurology physician affiliated with University of Southern California. OpenAlex indexes 43 publications with 546 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1520 San Pablo St Ste 3800
Los Angeles, CA 900335328
Telephone
323-442-5720Provider last certified this registry record 8 Dec 2021.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Research & Development, LLCProgram year20255 payments
- Abbott LaboratoriesProgram year20257 payments
- Janssen Global Services, LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
83.8%Aromatic Amino Acid Decarboxylation Inhibitor42.6%Carbidopa-Levodopa47%Carbidopa-Levodopa Er29%Rytary25%Part D≥27 patientsSSRI11.7%Escitalopram Oxalate49%Sertraline Hcl26%Trazodone Hcl26%Part D<11 patients+ 6 more classes in this area
Hormonal (systemic)
5%Mineralocorticoids5%Fludrocortisone Acetate100%Part D<11 patientsGenitourinary & hormones
5%beta3-Adrenergic Agonist5%Myrbetriq100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Deep brain stimulation access in 2025: geographic, gender, racial, and socioeconomic disparities re-examined
Current Opinion in Neurology
2025 - Beta-band desynchronization in the human hippocampus during movement preparation in a delayed reach task
Experimental Brain Research
2025
Similar KOLs
Other experts from the same institution or the same specialty.
David Liebeskind, MD
University of Southern California
Lon Schneider, MD
University of Southern California
Amytis Towfighi, MD
University of Southern California
Norah Terrault, MD
University of Southern California
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”